Works matching DE "GOSERELIN"

Results: 136

Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.

Published in:

Journal of Obstetrics & Gynaecology Research, 2016, v. 42, n. 9, p. 1152, doi. 10.1111/jog.13023

By:

Takaesu, Yotaro;
Nishi, Hirotaka;
Kojima, Junya;
Sasaki, Toru;
Nagamitsu, Yuzo;
Kato, Rina;
Isaka, Keiichi

Publication type:

Article

Advanced prostate cancer. Endocrine therapies and palliative measures.

Published in:

1996

By:

Taub, M;
Begas, A;
Love, N

Publication type:

journal article

Luteinizing hormone release after administration of the gonadotropin-releasing hormone agonist Fertilan (goserelin) for synchronization of ovulation in pigs.

Published in:

Journal of Animal Science, 2007, v. 85, n. 1, p. 129, doi. 10.2527/jas.2006-281

By:

Brüssow, K.-P.;
Schneider, L. F.;
Tuchscherer, A.;
Rátky, J.;
Kraeling, R. R.;
Kanitz, W.

Publication type:

Article

Adjuvant goserelin improves clinical disease-free survival and reduces disease-related mortality in patients with locally advanced or localized prostate cancer.

Published in:

BJU International, 2004, v. 93, n. 1, p. 42, doi. 10.1111/j.1464-410X.2004.04552.x

By:

Akaza, H.

Publication type:

Article

Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer.

Published in:

BJU International, 1999, v. 83, n. 7, p. 801, doi. 10.1046/j.1464-410x.1999.00028.x

By:

Sarosdy;
Schellhammer;
Soloway;
Vogelzang;
Crawford;
Presti;
Chodak;
Mitchell;
Porter

Publication type:

Article

Chronic urticaria due to autoreactivity to progesterone.

Published in:

Clinical & Experimental Dermatology, 2015, v. 40, n. 6, p. 644, doi. 10.1111/ced.12632

By:

Wingate‐Saul, L.;
Rymer, J.;
Greaves, M. W.

Publication type:

Article

Benign familial pemphigus--premenstrual exacerbation suppressed by goserelin and oophorectomy.

Published in:

Clinical & Experimental Dermatology, 1995, v. 20, n. 1, p. 54, doi. 10.1111/j.1365-2230.1995.tb01284.x

By:

James, M. P.;
Williams, R. M.

Publication type:

Article

Pemphigoid gestationis -- response to chemical oophorectomy with goserelin.

Published in:

Clinical & Experimental Dermatology, 1992, v. 17, n. 6, p. 443, doi. 10.1111/j.1365-2230.1992.tb00256.x

By:

Garvey, M. P.;
Handfield-Jones, S. E.;
Black, M. M.

Publication type:

Article

Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea.

Published in:

Cancer Research & Treatment, 2015, v. 47, n. 1, p. 55, doi. 10.4143/crt.2013.165

By:

Juan Zhou;
San-Gang Wu;
Jun-Jie Wang;
Jia-Yuan Sun;
Feng-Yan Li;
Qin Lin;
Huan-Xin Lin;
Zhen-Yu He

Publication type:

Article

O valor da histeroscopia diagnóstica com biópsia no pré-operatório de ablação endometrial.

Published in:

Einstein (16794508), 2011, v. 9, n. 4, p. 499, doi. 10.1590/s1679-45082011ao2094

By:

Yatabe, Salete;
Gomes Pereira, Ana Maria;
Takeda, Gilberto Kendi;
de Baptista Depes, Daniela;
Coelho Lopes, Reginaldo Guedes

Publication type:

Article

Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial.

Published in:

British Journal of Cancer, 2013, v. 109, n. 3, p. 582, doi. 10.1038/bjc.2013.324

By:

Yang, H;
Zong, X;
Yu, Y;
Shao, G;
Zhang, L;
Qian, C;
Bian, Y;
Xu, X;
Sun, W;
Meng, X;
Ding, X;
Chen, D;
Zou, D;
Xie, S;
Zheng, Y;
Zhang, J;
He, X;
Sun, C;
Yu, X;
Ni, J

Publication type:

Article

Palbociclib.

Published in:: Australian Prescriber, 2018, v. 41, n. 4, p. 127, doi. 10.18773/austprescr.2018.029
Publication type:: Article

Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VII.

Published in:

Scandinavian Journal of Urology (Taylor & Francis Ltd), 2014, v. 48, n. 6, p. 513, doi. 10.3109/21681805.2014.901410

By:

Salonen, Arto J.;
Taari, Kimmo;
Ala-Opas, Martti;
Sankila, Anna;
Viitanen, Jouko;
Lundstedt, Seppo;
Tammela, Teuvo L. J.

Publication type:

Article

Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.

Published in:

Medical Oncology, 2013, v. 30, n. 1, p. 1, doi. 10.1007/s12032-012-0354-1

By:

Aydiner, Adnan;
Kilic, Leyla;
Yildiz, Ibrahim;
Keskin, Serkan;
Sen, Fatma;
Kucucuk, Seden;
Karanlik, Hasan;
Muslumanoglu, Mahmut;
Igci, Abdullah

Publication type:

Article

Goserelin: A Review of its Use in the Treatment of Early Breast Cancer in Premenopausal and Perimenopausal Women.

Published in:

Drugs, 2005, v. 65, n. 18, p. 2639, doi. 10.2165/00003495-200565180-00011

By:

Cheer, Susan M.;
Plosker, Greg L.;
Simpson, Dene;
Wagstaff, Antona J.

Publication type:

Article

Both Castration and Goserelin Acetate Ameliorate Myocardial Ischemia Reperfusion Injury and Apoptosis in Male Rats.

Published in:

ISRN Otolaryngology, 2014, p. 1, doi. 10.1155/2014/206951

By:

Hadi, Najah R.;
Yusif, Fadhil G.;
Yousif, Maitham;
Jaen, Karrar K.

Publication type:

Article

Profiling and in vivo Quantification of Proteins by High Resolution Mass Spectrometry: The Example of Goserelin, an Analogue of Luteinizing Hormone-Releasing Hormone.

Published in:

Clinical Chemistry & Laboratory Medicine, 2003, v. 41, n. 12, p. 1589, doi. 10.1515/CCLM.2003.242

By:

Michalet, Sophie;
Favreau, Philippe;
Stöcklin, Reto

Publication type:

Article

Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary.

Published in:

2015

By:

Meurs, Hannah S.;
Velden, Jacobus;
Buist, Marrije R.;
Driel, Willemien J.;
Kenter, Gemma G.;
Lonkhuijzen, Luc R.C.W.

Publication type:

journal article

Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure.

Published in:

2003

By:

Bozzini, Nilo;
Rodrigues, Consuelo J.;
Petti, Domingos A.;
Bevilacqua, Ruy G.;
GonÇalves, Sergio P.;
Pinotti, José Aristodemo;
Gonçalves, Sergio P;
Pinotti, José Aristodemo

Publication type:

journal article

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer.

Published in:

2005

By:

Hasan, J.;
Ton, N.;
Mullamitha, S.;
Clamp, A.;
McNeilly, A.;
Marshall, E.;
Jayson, G. C.

Publication type:

journal article

A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer.

Published in:

2005

By:

De Placido, S.;
De Laurentiis, M.;
De Lena, M.;
Lorusso, V.;
Paradiso, A.;
D'Aprile, M.;
Pistillucci, G.;
Farris, A.;
Sarobba, M. G.;
Palazzo, S.;
Manzione, L.;
Adamo, V.;
Palmeri, S.;
Ferraù, F.;
Lauria, R.;
Pagliarulo, C.;
Petrella, G.;
Limite, G.;
Costanzo, R.;
Bianco, A. R.

Publication type:

journal article

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.

Published in:

British Journal of Cancer, 2004, v. 90, n. 3, p. 590, doi. 10.1038/sj.bjc.6601557

By:

Forward, D. P.;
Cheung, K. L.;
Jackson, L.;
Robertson, J. F. R.

Publication type:

Article

Goserelin (Zoladex<sup>™</sup>) – its role in early breast cancer in pre- and perimenopausal women.

Published in:

2002

By:

Jonat, W

Publication type:

Erratum

Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women.

Published in:

British Journal of Cancer, 2001, v. 85, p. 1

By:

Jonat, W

Publication type:

Article

Prolactin, TNF alpha and nitric oxide expression in nitroso-N-methylurea-induced-mammary tumours.

Published in:

Journal of Carcinogenesis, 2007, v. 6, n. 1, p. 18, doi. 10.1186/1477-3163-6-18

By:

Vegh, Irene;
de Salamanca, Rafael Enríquez

Publication type:

Article

Practicalities in GnRH agent administration for advanced prostate cancer.

Published in:: Urology Times, 2023, v. 51, n. 9, p. 20
Publication type:: Article

Clinical outcome after treatment of pelvic congestion syndrome: Sense and nonsense.

Published in:

Phlebology, 2015, v. 30, p. 73, doi. 10.1177/0268355514568067

By:

Meissner, MH;
Gibson, K

Publication type:

Article

Effects of endurance training on combined goserelin acetate and doxorubicin treatment-induced cardiac dysfunction.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 685, doi. 10.1007/s00280-010-1523-6

By:

Hydock, David;
Parry, Traci;
Jensen, Brock;
Lien, Chia-Ying;
Schneider, Carole;
Hayward, Reid

Publication type:

Article

Administration of Goserelin at Alternative Injection Sites for Premenopausal Breast Cancer.

Published in:

Clinical Journal of Oncology Nursing, 2024, v. 28, n. 6, p. 582, doi. 10.1188/24.CJON.582-588

By:

Baggarley, Taylor;
Manjunath, Nikhil;
Cannon, Joan;
Young, Stacia A.;
Sheen, Melanie A.

Publication type:

Article

Study supports first-line combination endocrine therapy for premenopausal breast cancer.

Published in:: Formulary, 2000, v. 35, n. 2, p. 128
Publication type:: Article

Initial growth deceleration during GnRH analogue therapy for precocious puberty.

Published in:

Clinical Endocrinology, 2009, v. 70, n. 5, p. 751, doi. 10.1111/j.1365-2265.2008.03433.x

By:

Mouat, Frances;
Hofman, Paul L.;
Jefferies, Craig;
Gunn, Alistair Jan;
Cutfield, Wayne S.

Publication type:

Article

Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.

Published in:

Clinical Endocrinology, 2004, v. 61, n. 5, p. 626, doi. 10.1111/j.1365-2265.2004.02146.x

By:

Paterson, W. F.;
McNeill, E.;
Young, D.;
Donaldson, M. D. C.

Publication type:

Article

Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.

Published in:

Clinical Endocrinology, 2002, v. 57, n. 2, p. 223, doi. 10.1046/j.1365-2265.2002.01571.x

By:

Trueman, Julie A.;
Tillmann, Vallo;
Cusick, Colin F.;
Foster, Peter;
Patel, Leena;
Hall, Catherine M.;
Price, David A.;
Clayton, Peter E.

Publication type:

Article

Cutaneous endometriosis: a combination of medical and surgical treatment.

Published in:

Journal of Dermatological Treatment, 2002, v. 13, n. 4, p. 189

By:

Kang, S.-K.;
Lee, M.-W.;
Choi, J.-H.;
Sung, K.-J.;
Moon, K.-C.;
Koh, J.-K.

Publication type:

Article

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.

Published in:

Clinical Medicine Insights: Reproductive Health, 2019, v. 13, n. 2, p. N.PAG, doi. 10.1177/1179558119864584

By:

Poggio, Francesca;
Lambertini, Matteo;
Bighin, Claudia;
Conte, Benedetta;
Blondeaux, Eva;
D'Alonzo, Alessia;
Dellepiane, Chiara;
Buzzatti, Giulia;
Molinelli, Chiara;
Boccardo, Francesco;
Del Mastro, Lucia

Publication type:

Article

Chemical ablation of endometrium with trichloroacetic acid

Published in:

2004

By:

Kucukozkan, T.;
Kadioglu, B.G.;
Uygur, D.;
Moroy, P.;
Mollamahmutoglu, L.;
Besli, M.

Publication type:

journal article

GnRH analogues as an adjuvant therapy for ovarian cancer patients

Published in:

2003

By:

Rzepka-Górska, I.;
Chudecka-Glaz, A.;
Kosmider, M.;
Malecha, J.;
Rzepka-Górska, I

Publication type:

journal article

Extending the treatment boundaries: Zoladex and add-back.

Published in:

1999

By:

Schlaff, W D

Publication type:

journal article

Gonadotropin releasing hormone agonist treatment before hysteroscopic endometrial resection.

Published in:

1994

By:

Vercellini, P.;
Trespidi, L.;
Bramante, T.;
Panazza, S.;
Mauro, F.;
Crosignani, P.G.

Publication type:

journal article

Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer.

Published in:

International Journal of Clinical Oncology, 2013, v. 18, n. 3, p. 524, doi. 10.1007/s10147-012-0413-9

By:

Ishizuka, Osamu;
Nishizawa, Osamu;
Nishizawa, Shuji;
Satoh, Tomoya;
Wajiki, Masahisa;
Kiyokawa, Hideo;
Inoue, Yoshihiro;
Kobayashi, Shinya;
Mizusawa, Hiroya;
Nakagawa, Tatsuo

Publication type:

Article

Effectiveness of skin icing in reducing pain associated with goserelin acetate injection.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 5, p. 472, doi. 10.1007/s10147-010-0095-0

By:

Kinoshita, Hidefumi;
Kawa, Gen;
Hiura, Yoshihito;
Chizaki, Ryusuke;
Matsuda, Tadashi

Publication type:

Article

Degarelix versus Goserelin plus Bicalutamide Therapy for Lower Urinary Tract Symptom Relief, Prostate Volume Reduction and Quality of Life Improvement in Men with Prostate Cancer: A Systematic Review and Meta-Analysis.

Published in:

Urologia Internationalis, 2014, v. 93, n. 2, p. 152, doi. 10.1159/000356272

By:

Cui, Yuanshan;
Zong, Huantao;
Yan, Huilei;
Li, Nan;
Zhang, Yong

Publication type:

Article

Fifteen-Second Skin Icing Using a Frozen Gel Pack Is Effective for Reducing Goserelin Injection Pain.

Published in:

Urologia Internationalis, 2014, v. 93, n. 2, p. 202, doi. 10.1159/000353917

By:

Naya, Yoshio;
Hagiwara, Nobuhisa;
Takeuchi, Ichiro;
Mori, Masaru;
Inagaki, Akinori;
Nakanouchi, Tsuneyuki;
Mikami, Kazuya

Publication type:

Article

Degarelix versus Goserelin (+ Antiandrogen Flare Protection) in the Relief of Lower Urinary Tract Symptoms Secondary to Prostate Cancer: Results from a Phase IIIb Study (NCT00831233).

Published in:

Urologia Internationalis, 2013, v. 90, n. 3, p. 321, doi. 10.1159/000345423

By:

anderson, John;
al-ali, Ghandi;
Wirth, Manfred;
Gual, Joan Benejam;
Gomez Veiga, Francisco;
Colli, Enrico;
van der Meulen, Egbert;
Persson, Bo-Eric

Publication type:

Article

3-Month Formulation of Goserelin Acetate ('Zoladex' 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial.

Published in:

Urologia Internationalis, 2003, v. 70, n. 4, p. 316, doi. 10.1159/000070142

By:

Fontana, D.;
Mari, M.;
Martinelli, A.;
Boccafoschi, C.;
Magno, C.;
Turriziani, M.;
Maymone, S. S.;
Cunico, S. Cosciani;
Zanollo, A.;
Montagna, G.;
Frongia, M.;
Jacobellis, U.

Publication type:

Article

Prostate-Specific Antigen Dynamics Predict Risk of Progression in Advanced Prostate Cancer Treated with Bicalutamide plus Castration.

Published in:

Urologia Internationalis, 2002, v. 68, n. 4, p. 220, doi. 10.1159/000058439

By:

Altwein, Jens E.;
Schmidt, Andreas

Publication type:

Article

Cellular leiomyoma mimicking endometrial stromal neoplasm in association with GnRH agonist goserelin.

Published in:

Histopathology, 1999, v. 34, n. 2, p. 184

By:

McCluggage;
Bharucha

Publication type:

Article

Evaluation of goserelin effectiveness based on assessment of inflammatory cytokines and symptoms in uterine leiomyoma.

Published in:

2020

By:

Mohammed, Nadia H.;
Al-Taie, Anmar;
Albasry, Zahraa

Publication type:

journal article

Both Castration and Goserelin Acetate Ameliorate Myocardial Ischemia Reperfusion Injury and Apoptosis in Male Rats.

Published in:

ISRN Pharmacology, 2014, p. 1, doi. 10.1155/2014/206951

By:

Hadi, Najah R.;
Yusif, Fadhil G.;
Yousif, Maitham;
Jaen, Karrar K.

Publication type:

Article

Abstracts.

Published in:

1995

By:

Smith, Jeanette M.;
Cole, Thomas B.

Publication type:

Abstract